Skip to main content

Table 1 Summary of patients’ data used for quantitative analysis

From: 3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright-blood coronary CMR angiography

 

Gender

Age (years)

Heartbeats

per minute

Clinical Condition

LGE findings

3D whole heart

CMRA

Patient 01

F

25

85

Atrial fibrillation

No

Yes

Patient 02

F

30

70

Atrial fibrillation

(previous myocarditis)

No

No

Patient 03

F

48

70

Eosinophilic Granulomatous Polyangitis (Churg-Strauss syndrome)

No

No

Patient 04

M

50

80

Myocarditis

Yes

Diffuse mid-wall

No

Patient 05

M

67

55

Myocardial infarction

Yes

Transmural

No

Patient 06

M

56

65

Advanced Hypertensive

heart disease

No

(no 2D PSIR)

Yes

Patient 07

M

66

70

Myocardial infarction

Yes

Transmural and subendocardial

No

Patient 08

M

62

80

Myocardial infarction

Yes

Mid-wall

Yes

Patient 09

M

59

45

Myocardial infarction

Yes

Subendocardial

Yes

Patient 10

F

30

75

Myocardial infarction

Yes

Subendocardial

Yes

Patient 11

F

74

80

Myocardial infarction

Yes

Transmural

No

Patient 12

M

52

75

Suspected myocardial infarction

No

(no 2D PSIR)

Yes

  1. Furthermore, the presence of LGE findings is stated (“no 2D PSIR” pertains the cases where 2D PSIR acquisition was not performed and presence of LGE uptake was assessed with BOOST only). In addition, it is indicated whether the acquisition of the conventional, 3D whole-heart CMRA sequence was performed or not